Tianjin Zhongxin Pharmaceutical Analyst Reports

SGX Listed Stock

TIANJIN ZHONG XIN PHARM GROUP (SGX:T14)



TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) has changed the issuer name / code to TIANJIN PHARM DA REN TANG GRP (SGX:T14) with effect from 2022-05-24.

See TIANJIN PHARM DA REN TANG GRP (SGX:T14)'s analyst reports.


TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) @ SGinvestors.io
USD ***.**
-----
Share Price as of: -
ISIN Code:
Market: SGX Mainboard
Sector / Industry: Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals


Tianjin Zhongxin Pharmaceutical Analyst Research ReportsTIANJIN ZHONG XIN PHARM GROUP Analyst Research Reports SGX Listed Tianjin Zhongxin Pharmaceutical (SGX:T14) Analyst Research Reports T14.SI Analyst Research Reports



Analyst Report
Analysts Say
Tianjin Zhongxin Pharmaceutical Analyst Reports

Your Say


SGX Stock / REIT Search

-

Sign up Trust Bank Credit Card or open a Trust Bank savings account using referral code PGKPSWAE in November 2025: โœจEarn up to S$1,000 cashback reward ๐ŸŽŸ and win an XPENG G6 SUV ๐Ÿš™ !
-
Get AI Browser Comet with a free month of Perplexity Pro โ€” Limited-Time Offer !